Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
159 hedge funds and large institutions have $1.24B invested in Portola Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 64 increasing their positions, 46 reducing their positions, and 28 closing their positions.
138% more call options, than puts
Call options by funds: $4.22M | Put options by funds: $1.78M
39% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 46
15% more capital invested
Capital invested by funds: $1.08B → $1.24B (+$158M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 167 → 159 (-8)
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$15M |
| 2 |
PA
Pinnacle Associates
New York
|
+$14.4M |
| 3 |
DM
Deerfield Management
New York
|
+$14.4M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$14.2M |
| 5 |
Millennium Management
New York
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$18.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.9M |
| 3 |
O
OrbiMed
New York
|
-$11.5M |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$9.29M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$8.98M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PPA
176
Parametric Portfolio Associates
Seattle,
Washington
| – | -$235K | -11,528 | Closed |
|
177
M&T Bank
Buffalo,
New York
| – | -$233K | -11,397 | Closed |
|
|
TAM
178
Tocqueville Asset Management
New York
| – | -$217K | -10,650 | Closed |
|
|
GAMA
179
Graticule Asia Macro Advisors
New York
| – | -$206K | -10,118 | Closed |
|
|
ST
180
Spot Trading
Chicago,
Illinois
| – | -$134K | -5,430 | Closed |
|
181
Walleye Trading
New York
| – | -$51K | -2,500 | Closed |
|
|
MMG
182
Monetary Management Group
St Louis,
Missouri
| – | -$46K | -2,250 | Closed |
|
183
Envestnet Asset Management
Chicago,
Illinois
| – | -$26K | -1,288 | Closed |
|
184
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$5K | -273 | Closed |
|
|
DADC
185
D.A. Davidson & Co
Great Falls,
Montana
| – | -$1K | -57 | Closed |
|
|
LWCFA
186
Loring Wolcott & Coolidge Fiduciary Advisors
Boston,
Massachusetts
| – | +$247 | +10 | New |
|
|
PRS
187
Pinkerton Retirement Specialists
Coeur D Alene,
Idaho
| – | +$444 | +18 | New |
|
PTLA Hedge Fund Activity: Q2 2016 in Review
159 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q2 2016, worth a combined $1.24B — up 15% from $1.08B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of PTLA and 22 opened new positions — a net loss of 6 holders — while 46 trimmed existing stakes and 64 added.
The largest buyer was Pictet Asset Management (UK), adding an estimated $15M. The largest seller was Franklin Resources, cutting an estimated $18.3M.
- 159 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q2 2016, down from 167 in Q1 2016.
- Funds reported $1.24B of Portola Pharmaceuticals, Inc. stock for Q2 2016, up 15% quarter-over-quarter.
- 22 funds opened new Portola Pharmaceuticals, Inc. positions in Q2 2016 and 28 closed out, a net change of -6 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q2 2016 was Pictet Asset Management (UK), an estimated $15M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q2 2016 was Franklin Resources, an estimated $18.3M sold.
Based on aggregated 13F filings for Q2 2016.